Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Integr Care ; 23(4): 16, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38107835

RESUMEN

The COVID-19 pandemic has mandated a re-imagination of how healthcare is administered and delivered, with a view towards focusing on person-centred care and advancing population health while increasing capacity, access and equity in the healthcare system. These goals can be achieved through healthcare integration. In 2019, the University Health Network (UHN), a consortium of four quaternary care hospitals in Ontario, Canada, established the first stage of a pilot program to increase healthcare integration at the institutional level and vertically with other primary, secondary and tertiary institutions in the Ontario healthcare system. Implementation of the program was accelerated during the COVID-19 pandemic and demonstrated how healthcare integration improves person-centred care and population health; therefore serving as the foundation for a health system response for the COVID-19 pandemic recovery and beyond.

2.
J Obstet Gynaecol Can ; 28(2): 142-8, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16643717

RESUMEN

OBJECTIVE: Early abortions have been predominantly surgical for many years, but medical options with comparable efficacy and safety are now available. This study compares the costs of two medical options and two surgical options. METHODS: We used a clinical model to compare the costs in Ontario of four options for early abortion: medical abortion using either mifepristone or methotrexate, and surgical abortion by vacuum aspiration in either a hospital or a free-standing clinic. The cost analysis was conducted from the perspectives of society, the health care system, and the patient. RESULTS: From all perspectives, total costs were highest for hospital surgical abortion, followed by surgical abortion in a clinic. From the patient's perspective, total costs were higher for surgical abortion but direct costs (mainly for medications) were higher for medical abortion. The total cost of mifepristone and methotrexate abortion was equal if the price of mifepristone (200 mg) was $59.52. The model was robust but was sensitive to the price of mifepristone. CONCLUSION: Early medical abortion costs less than early surgical abortion from the societal and health care system perspectives but more than surgical abortion from the patient's perspective. Surgical abortion costs more in hospitals than in free-standing clinics from the societal and health care system perspectives, but the costs are the same in both settings from the patient's perspective. No method for early abortion can be identified as best, and patients should be free to choose the option they prefer.


Asunto(s)
Abortivos Esteroideos/economía , Aborto Inducido/economía , Aborto Inducido/métodos , Instituciones de Atención Ambulatoria , Servicio Ambulatorio en Hospital , Legrado por Aspiración/economía , Abortivos Esteroideos/farmacología , Instituciones de Atención Ambulatoria/economía , Femenino , Humanos , Metotrexato/economía , Metotrexato/farmacología , Mifepristona/economía , Mifepristona/farmacología , Ontario , Servicio Ambulatorio en Hospital/economía , Embarazo , Legrado por Aspiración/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...